Macrocylics
Macrocyclics, Inc. is a CDMO specializing in chelating agents for radiopharmaceuticals and nuclear medicine. A subsidiary of Orano Med, the company provides custom synthesis, kilo-scale manufacturing, and bioconjugation services to accelerate early-stage pharmaceutical development. The company maintains a small catalog of bifunctional chelating agents, complexes, and reactive intermediates that support
discovery and clinical research programs. Both catalog and custom products can be made using GMP, applying phase appropriate controls for raw materials and drug substances.
